Common antidepressant alleviates long-term COVID fatigue
A new study reveals that the drug fluvoxamine, typically used as an antidepressant, significantly improves the quality of life for adults suffering from long-term COVID. Conducted in Brazil, the clinical trial involved 399 participants experiencing fatigue for at least 90 days post-infection.